The c-Met Inhibitor MSC2156119J Effectively Inhibits Tumor Growth in Liver Cancer Models
Friedhelm Bladt(Bayer (Germany)), Andree Blaukat(Merck KGaA, Darmstadt (Germany))
Cited by 61
Related Papers
Phosphorylation by casein kinase 2 induces PACS‐1 binding of nephrocystin and targeting to cilia
|The EMBO Journal|2005|95
A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer Therapies
|Molecular Cancer Therapeutics|2022|50